Total Payments
$1,805
2022 Payments
$52.65
Companies
19
Transactions
92
Medicare Patients
7,659
Medicare Billing
$761,824
Payment Breakdown by Category
Food & Beverage$1,431 (79.3%)
Education$373.50 (20.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,431 | 88 | 79.3% |
| Education | $373.50 | 4 | 20.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $547.06 | 38 | $0 (2022) |
| Janssen Biotech, Inc. | $273.73 | 6 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $199.46 | 7 | $0 (2019) |
| Genentech USA, Inc. | $184.77 | 12 | $0 (2019) |
| Pharmacyclics LLC, An AbbVie Company | $163.97 | 6 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $90.50 | 1 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $76.50 | 4 | $0 (2019) |
| Teva Pharmaceuticals USA, Inc. | $50.49 | 4 | $0 (2018) |
| TESARO, Inc. | $47.88 | 3 | $0 (2017) |
| PFIZER INC. | $26.96 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $52.65 | 3 | Novartis Pharmaceuticals Corporation ($19.77) |
| 2019 | $750.14 | 33 | Novartis Pharmaceuticals Corporation ($231.48) |
| 2018 | $367.07 | 20 | Pharmacyclics LLC, An AbbVie Company ($144.45) |
| 2017 | $635.03 | 36 | Novartis Pharmaceuticals Corporation ($295.81) |
All Payment Transactions
92 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/04/2022 | Novartis Pharmaceuticals Corporation | PIQRAY (Drug) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: ONCOLOGY | ||||||
| 04/29/2022 | Celgene Corporation | ONUREG (Drug) | Food and Beverage | Cash or cash equivalent | $18.10 | General |
| Category: Oncology | ||||||
| 02/14/2022 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/15/2019 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug), TASIGNA | Food and Beverage | In-kind items and services | $10.98 | General |
| Category: ONCOLOGY | ||||||
| 10/08/2019 | Janssen Biotech, Inc. | DARZALEX (Biological) | Education | In-kind items and services | $85.00 | General |
| Category: Oncology | ||||||
| 09/27/2019 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug), TASIGNA | Food and Beverage | In-kind items and services | $12.22 | General |
| Category: ONCOLOGY | ||||||
| 09/23/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $26.05 | General |
| Category: Oncology | ||||||
| 08/09/2019 | PFIZER INC. | IBRANCE (Drug) | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: ONCOLOGY | ||||||
| 08/01/2019 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug), TASIGNA | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: ONCOLOGY | ||||||
| 07/26/2019 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $10.17 | General |
| Category: ONCOLOGY | ||||||
| 07/11/2019 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug), TASIGNA | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: ONCOLOGY | ||||||
| 06/14/2019 | Takeda Pharmaceuticals U.S.A., Inc. | VELCADE (Drug) | Education | In-kind items and services | $90.50 | General |
| Category: Oncology | ||||||
| 06/06/2019 | Genentech USA, Inc. | Perjeta (Biological) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: BioOncology | ||||||
| 06/03/2019 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: ONCOLOGY | ||||||
| 05/23/2019 | Genentech USA, Inc. | VENCLEXTA (Biological) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: BioOncology | ||||||
| 05/13/2019 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug), TASIGNA | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: ONCOLOGY | ||||||
| 05/13/2019 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug), TASIGNA | Food and Beverage | In-kind items and services | $1.56 | General |
| Category: ONCOLOGY | ||||||
| 05/06/2019 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Oncology | ||||||
| 05/06/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: ONCOLOGY | ||||||
| 05/03/2019 | Novartis Pharmaceuticals Corporation | SANDOSTATIN (Drug) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: ONCOLOGY | ||||||
| 04/18/2019 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $21.60 | General |
| Category: Oncology | ||||||
| 04/16/2019 | Genentech USA, Inc. | Perjeta (Biological), TECENTRIQ | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: BioOncology | ||||||
| 04/16/2019 | Genentech USA, Inc. | Perjeta (Biological), TECENTRIQ | Food and Beverage | In-kind items and services | $11.60 | General |
| Category: BioOncology | ||||||
| 04/09/2019 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Immunology | ||||||
| 04/08/2019 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug), TASIGNA | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 31 | 2,021 | 8,957 | $749,630 | $204,974 |
| 2021 | 36 | 2,686 | 17,745 | $1.1M | $311,230 |
| 2020 | 44 | 2,952 | 18,119 | $948,009 | $245,620 |
Total Patients
7,659
Total Services
44,821
Medicare Billing
$761,824
Procedure Codes
111
All Medicare Procedures & Services
111 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 11 | 3,780 | $245,100 | $64,715 | 26.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 185 | 356 | $135,280 | $38,629 | 28.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 167 | 408 | $106,080 | $31,405 | 29.6% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 16 | 91 | $50,125 | $12,452 | 24.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 260 | 893 | $24,105 | $6,822 | 28.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 239 | 529 | $18,705 | $5,474 | 29.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 51 | 90 | $14,400 | $4,653 | 32.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 18 | 28 | $14,280 | $4,628 | 32.4% |
| 82378 | Carcinoembryonic antigen (cea) protein level | Office | 2022 | 127 | 240 | $16,290 | $4,462 | 27.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 19 | 19 | $13,870 | $3,903 | 28.1% |
| 99195 | Drawing of blood for a medical problem | Office | 2022 | 12 | 33 | $13,485 | $3,141 | 23.3% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2022 | 16 | 184 | $11,540 | $2,886 | 25.0% |
| 86300 | Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | Office | 2022 | 96 | 138 | $9,660 | $2,843 | 29.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 259 | 888 | $10,730 | $2,614 | 24.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 28 | 181 | $10,860 | $2,404 | 22.1% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2022 | 11 | 71 | $7,950 | $2,043 | 25.7% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2022 | 11 | 66 | $8,080 | $1,959 | 24.2% |
| 82784 | Gammaglobulin (immune system protein) measurement | Office | 2022 | 44 | 207 | $6,210 | $1,882 | 30.3% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 12 | 29 | $8,105 | $1,821 | 22.5% |
| 96361 | Infusion into a vein for hydration, each additional hour | Office | 2022 | 13 | 108 | $5,685 | $1,371 | 24.1% |
| 82728 | Ferritin (blood protein) level | Office | 2022 | 49 | 74 | $3,590 | $985.42 | 27.4% |
| 83615 | Lactate dehydrogenase (enzyme) level | Office | 2022 | 106 | 147 | $3,240 | $877.74 | 27.1% |
| 83550 | Iron binding capacity | Office | 2022 | 52 | 80 | $2,680 | $683.78 | 25.5% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2022 | 31 | 35 | $1,930 | $518.14 | 26.8% |
| 83540 | Iron level | Office | 2022 | 52 | 80 | $1,740 | $506.26 | 29.1% |
About Dr. Paula Schwartz, M.D
Dr. Paula Schwartz, M.D is a Specialist healthcare provider based in New Hyde Park, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780769877.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paula Schwartz, M.D has received a total of $1,805 in payments from pharmaceutical and medical device companies, with $52.65 received in 2022. These payments were reported across 92 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,431).
As a Medicare-enrolled provider, Schwartz has provided services to 7,659 Medicare beneficiaries, totaling 44,821 services with total Medicare billing of $761,824. Data is available for 3 years (2020–2022), covering 111 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location New Hyde Park, NY
- Active Since 10/26/2006
- Last Updated 07/08/2007
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1780769877
Products in Payments
- TASIGNA (Drug) $173.71
- Imbruvica (Drug) $163.97
- IMBRUVICA (Drug) $141.24
- PROMACTA (Drug) $128.41
- DARZALEX (Biological) $106.44
- KEYTRUDA (Biological) $100.22
- VELCADE (Drug) $90.50
- JADENU (Drug) $84.56
- OPDIVO (Biological) $76.50
- MEKINIST (Drug) $73.09
- Perjeta (Biological) $58.07
- BENDEKA (Drug) $50.49
- ZEJULA (Drug) $47.88
- SANDOSTATIN (Drug) $41.59
- TECENTRIQ (Biological) $38.03
- GAZYVA (Biological) $29.18
- Erleada (Drug) $26.05
- PIQRAY (Drug) $19.77
- Cabometyx (Drug) $19.47
- ONUREG (Drug) $18.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in New Hyde Park
Dr. Elliott Salamon, Do, DO
Specialist — Payments: $52,956
Specialist $52,956
Dr. Andrew Porges, Md, MD
Specialist — Payments: $30,781
Specialist $30,781
Dr. Ivan Pavkovic, M.d, M.D
Specialist — Payments: $29,318
Specialist $29,318
Dr. Joseph Ramek, M.d, M.D
Specialist — Payments: $26,475
Specialist $26,475
Dr. Slavina Gardella, M.d, M.D
Specialist — Payments: $23,827
Specialist $23,827
Victor Katz, Md, MD
Specialist — Payments: $19,161
Specialist $19,161